November 2, 2016
Via: Mass DeviceAbiomed (NSDQ:ABMD) said today it launched the Impella quality assurance program, looking to improve outcomes for cardiogenic shock and protected PCI patients. The Danvers, Mass.-based company said the program will use data from its IQ Database, which includes observational quality assurance data […]
July 9, 2024
June 25, 2024